Healio1d
VIDEO: Excimer laser trabeculostomy offers new option for MIGS
In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, explains excimer laser trabeculostomy for the ...
PharmiWeb1d
Refractive Surgery Device Market Poised for Steady Growth, Expected to Reach USD 312.3 Million by 2034 at a 3.90% CAGR
Refractive Surgery Device MarketThe global Refractive Surgery Device Market is projected to grow from USD 213.0 million in ...
Royal Bank of Canada Lowers Bausch + Lomb (NYSE:BLCO) Price Target to $22.00
Bausch + Lomb (NYSE:BLCO – Get Free Report) had its price objective lowered by stock analysts at Royal Bank of Canada from ...
Stifel Nicolaus Remains a Hold on Bausch + Lomb Corporation (BLCO)
Stifel Nicolaus analyst Thomas Stephan maintained a Hold rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a price ...
Bausch + Lomb's SWOT analysis: eye health stock faces challenges, opportunities
Bausch + Lomb Corporation (NYSE:BLCO; TSX:BLCO), a global eye health company, has been navigating a complex market landscape characterized by both promising opportunities and significant challenges.
Investing4d
RBC Capital Markets upgrades EssilorLuxottica citing growth potential
RBC Capital Markets has upgraded EssilorLuxottica (EPA: ESLX) to "outperform," citing strong fundamentals and growth ...
RBC Capital Issues a Buy Rating on Bausch + Lomb Corporation (BLCO)
In a report released today, Douglas Miehm from RBC Capital assigned a Buy rating to Bausch + Lomb Corporation (BLCO – Research Report), with a ...
American Association of Individual Investors4d
Which Is a Better Investment, Bausch + Lomb Corporation or Inari Medical, Inc. Stock?
Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.